Cargando…
Acute lysine supplementation does not improve hepatic or peripheral insulin sensitivity in older, overweight individuals
CONTEXT: Lysine supplementation may have a positive influence on the regulation of glucose metabolism but it has not been tested in the geriatric population. Objective: We evaluated the impact of acute lysine supplementation using three randomized experimental scenarios: 1) oral glucose alone (contr...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198625/ https://www.ncbi.nlm.nih.gov/pubmed/25324894 http://dx.doi.org/10.1186/1743-7075-11-49 |
_version_ | 1782339750369165312 |
---|---|
author | Kim, Il-Young Williams, Rick H Schutzler, Scott E Lasley, Cosby J Bodenner, Donald L Wolfe, Robert R Coker, Robert H |
author_facet | Kim, Il-Young Williams, Rick H Schutzler, Scott E Lasley, Cosby J Bodenner, Donald L Wolfe, Robert R Coker, Robert H |
author_sort | Kim, Il-Young |
collection | PubMed |
description | CONTEXT: Lysine supplementation may have a positive influence on the regulation of glucose metabolism but it has not been tested in the geriatric population. Objective: We evaluated the impact of acute lysine supplementation using three randomized experimental scenarios: 1) oral glucose alone (control), 2) oral glucose and low-dose lysine (2 grams), and oral glucose and high dose lysine (5 grams) lysine in 7 older (66 ± 1 years/age), overweight/obese (BMI = 28 ± 2 kg/m(2)) individuals. METHODS: We utilized a dual tracer technique (i.e., [6,6-(2)H(2)] glucose primed constant infusion and 1-[(13)C] glucose oral ingestion) during an oral glucose tolerance test (OGTT) to examine differences in hepatic and peripheral insulin sensitivity under all three scenarios. RESULTS: Post-absorptive plasma glucose and insulin concentrations were not different between the three trials. Similarly, the response of glucose and insulin concentrations during the oral glucose tolerance tests (OGTT) was similar in the three trials. The results of the Matsuda index (ISI/M) were also not different between the three trials. As an index of hepatic insulin sensitivity, there were no significant differences in the endogenous glucose rate of appearance (glucose R(a)) for control, 2 g lysine and 5 g lysine (1.2 ± 0.1, 1.1 ± 0.1, 1.3 ± 0.1 mg•kg(-1)•min(-1)), respectively. With respect to peripheral insulin sensitivity, there were no significant differences in the glucose rate of disappearance (glucose R(d)) for control, 2 g lysine and 5 g lysine (4.2 ± 0.1, 4.3 ± 0.2, and 4.5 ± 0.4 mg•kg(-1)•min(-1)), respectively. CONCLUSIONS: Previous studies in younger participants have suggested that lysine may have a beneficial effect on glucose metabolism. However, acute lysine supplementation in the older population does not facilitate beneficial changes in glucose R(a) or glucose R(d). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1743-7075-11-49) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4198625 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-41986252014-10-17 Acute lysine supplementation does not improve hepatic or peripheral insulin sensitivity in older, overweight individuals Kim, Il-Young Williams, Rick H Schutzler, Scott E Lasley, Cosby J Bodenner, Donald L Wolfe, Robert R Coker, Robert H Nutr Metab (Lond) Research CONTEXT: Lysine supplementation may have a positive influence on the regulation of glucose metabolism but it has not been tested in the geriatric population. Objective: We evaluated the impact of acute lysine supplementation using three randomized experimental scenarios: 1) oral glucose alone (control), 2) oral glucose and low-dose lysine (2 grams), and oral glucose and high dose lysine (5 grams) lysine in 7 older (66 ± 1 years/age), overweight/obese (BMI = 28 ± 2 kg/m(2)) individuals. METHODS: We utilized a dual tracer technique (i.e., [6,6-(2)H(2)] glucose primed constant infusion and 1-[(13)C] glucose oral ingestion) during an oral glucose tolerance test (OGTT) to examine differences in hepatic and peripheral insulin sensitivity under all three scenarios. RESULTS: Post-absorptive plasma glucose and insulin concentrations were not different between the three trials. Similarly, the response of glucose and insulin concentrations during the oral glucose tolerance tests (OGTT) was similar in the three trials. The results of the Matsuda index (ISI/M) were also not different between the three trials. As an index of hepatic insulin sensitivity, there were no significant differences in the endogenous glucose rate of appearance (glucose R(a)) for control, 2 g lysine and 5 g lysine (1.2 ± 0.1, 1.1 ± 0.1, 1.3 ± 0.1 mg•kg(-1)•min(-1)), respectively. With respect to peripheral insulin sensitivity, there were no significant differences in the glucose rate of disappearance (glucose R(d)) for control, 2 g lysine and 5 g lysine (4.2 ± 0.1, 4.3 ± 0.2, and 4.5 ± 0.4 mg•kg(-1)•min(-1)), respectively. CONCLUSIONS: Previous studies in younger participants have suggested that lysine may have a beneficial effect on glucose metabolism. However, acute lysine supplementation in the older population does not facilitate beneficial changes in glucose R(a) or glucose R(d). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1743-7075-11-49) contains supplementary material, which is available to authorized users. BioMed Central 2014-10-08 /pmc/articles/PMC4198625/ /pubmed/25324894 http://dx.doi.org/10.1186/1743-7075-11-49 Text en © Kim et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Kim, Il-Young Williams, Rick H Schutzler, Scott E Lasley, Cosby J Bodenner, Donald L Wolfe, Robert R Coker, Robert H Acute lysine supplementation does not improve hepatic or peripheral insulin sensitivity in older, overweight individuals |
title | Acute lysine supplementation does not improve hepatic or peripheral insulin sensitivity in older, overweight individuals |
title_full | Acute lysine supplementation does not improve hepatic or peripheral insulin sensitivity in older, overweight individuals |
title_fullStr | Acute lysine supplementation does not improve hepatic or peripheral insulin sensitivity in older, overweight individuals |
title_full_unstemmed | Acute lysine supplementation does not improve hepatic or peripheral insulin sensitivity in older, overweight individuals |
title_short | Acute lysine supplementation does not improve hepatic or peripheral insulin sensitivity in older, overweight individuals |
title_sort | acute lysine supplementation does not improve hepatic or peripheral insulin sensitivity in older, overweight individuals |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198625/ https://www.ncbi.nlm.nih.gov/pubmed/25324894 http://dx.doi.org/10.1186/1743-7075-11-49 |
work_keys_str_mv | AT kimilyoung acutelysinesupplementationdoesnotimprovehepaticorperipheralinsulinsensitivityinolderoverweightindividuals AT williamsrickh acutelysinesupplementationdoesnotimprovehepaticorperipheralinsulinsensitivityinolderoverweightindividuals AT schutzlerscotte acutelysinesupplementationdoesnotimprovehepaticorperipheralinsulinsensitivityinolderoverweightindividuals AT lasleycosbyj acutelysinesupplementationdoesnotimprovehepaticorperipheralinsulinsensitivityinolderoverweightindividuals AT bodennerdonaldl acutelysinesupplementationdoesnotimprovehepaticorperipheralinsulinsensitivityinolderoverweightindividuals AT wolferobertr acutelysinesupplementationdoesnotimprovehepaticorperipheralinsulinsensitivityinolderoverweightindividuals AT cokerroberth acutelysinesupplementationdoesnotimprovehepaticorperipheralinsulinsensitivityinolderoverweightindividuals |